Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 50
- Run by
- Mayo Clinic
See details and how to joinNCT06265285 - No phaseTaking peopleSmoking Cessation CM for Veterans With or at Risk for Cancer
- Where
- San Francisco
- Age
- 18 years and over
- People
- 108
- Run by
- VA Office of Research and Development
See details and how to joinNCT06432985 - Phase 3Taking peopleEffect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
- Where
- Oakland
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Pharmacosmos A/S
See details and how to joinNCT07473128 · EU 2025-525026-35-00 - No phaseNot yet taking people in United StatesPopulation Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)
- Where
- Salt Lake City
- Age
- 50 years to 80 years
- People
- 18,894
- Run by
- University of Utah
See details and how to joinNCT07599943 - No phaseTaking peopleProspective Multiomic Analysis in Small-Cell Lung Cancer
- Where
- Columbus
- Age
- 18 years and over
- People
- 30
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07795411 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Austin, Baltimore, Boston, Celebration, Charlottesville, Chicago, Cleveland, Dallas, Detroit, Durham, East Brunswick, Gainesville, Hackensack, Hershey, Indianapolis, Irving, Jacksonville, Las Vegas, Littleton, Louisville, Miami, Milwaukee, Myrtle Beach, Nashville, Newark, New Haven, New York, Omaha, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Plano, Plantation, Portland, Rochester, Santa Barbara, Syracuse, Tampa, Tucson, Tyler
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 1/2Taking peopleA Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
- Where
- Birmingham, Chicago, Detroit, East Brunswick, Fairfax, Hackensack, Jacksonville, Lancaster, Lebanon, Los Angeles, Milwaukee, Mineola, Minneapolis, Nashville, Newport Beach, New York, Orlando, Philadelphia, Phoenix, Rochester, Tampa, Vancouver
- Age
- 18 years and over
- People
- 123 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06362252 · EU 2023-509629-36-00 - Phase 1Taking peopleOpen-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Where
- Boston, Dallas, Duarte, Houston, Indianapolis, Kansas City, Los Angeles, Madison, Nashville, New York, San Antonio, San Diego, San Francisco, Seattle, St Louis, Tampa
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See details and how to joinNCT06625775 · EU 2024-519445-29-00 - Phase 2Taking peopleA Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
- Where
- Houston
- Age
- 18 years and over
- People
- 243 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT06907615 · EU 2025-523803-31-00 - Phase 1/2Taking people177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Where
- Dothan, Grand Rapids, Houston, Omaha
- Age
- 18 years and over
- People
- 61
- Run by
- Radiopharm Theranostics, Ltd
See details and how to joinNCT07189871 - Phase 1/2Taking peopleA Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
- Where
- Chicago, Clermont, Portland
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07286149 · EU 2024-512248-47-00 - Phase 1Not yet taking people in United StatesSBRT for Ultra-Central NonSmall Cell Lung Cancer
- Where
- Washington D.C.
- Age
- 18 years and over
- People
- 35
- Run by
- Georgetown University
See details and how to joinNCT07852247 - Phase 3Taking peopleAdaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
- Where
- Stanford
- Age
- 18 years and over
- People
- 48
- Run by
- Stanford University
See details and how to joinNCT04585490 - Phase 3Taking peopleNeladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Where
- Atlanta, Boston, Boulder, Charlotte, Cincinnati, Columbus, Detroit, Durham, Fairfax, Glendale, Miami, Nashville, Newport Beach, New York, Orange, Orlando, Seattle, Sellersville, St Louis, Tampa, Vancouver, Westbury
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT06765109 · EU 2024-517553-26-00 - Phase 1Taking peopleA First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Where
- Columbus, Fairfax, Farmington Hills, Grand Rapids, Houston, La Jolla, Morristown, Portland, Santa Monica, Spokane, Tampa, West Valley City
- Age
- 18 years and over
- People
- 170
- Run by
- ALX Oncology Inc.
See details and how to joinNCT07085091 - Phase 2Taking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - Phase 1Taking peopleA Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
- Where
- Fairfax, Maumee, Portland
- Age
- 18 years and over
- People
- 74
- Run by
- TwoStep Therapeutics, Inc.
See details and how to joinNCT07814248 - Phase 1Taking peopleA Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Where
- Boston, Charlotte, Duarte, Gilbert, Houston, Jacksonville, Los Angeles, Miami, Milwaukee, Nashville, New Brunswick, Newport Beach, New York, Pittsburgh, Portland, Round Rock, Santa Monica, Tampa, Winston-Salem
- Age
- 18 years and over
- People
- 45
- Run by
- AstraZeneca
See details and how to joinNCT05877599 - Phase 1Taking peopleA Study of PHN-012 in Patients With Advanced Solid Tumors
- Where
- Boston, Durham, Fairfax, Houston, Los Angeles, Nashville, Portland, San Antonio, San Diego, St Louis, Washington D.C.
- Age
- 18 years and over
- People
- 165 worldwide
- Run by
- Pheon Therapeutics
See details and how to joinNCT07127874 - Phase 1Taking peopleDK222 Study at Hopkins
- Where
- Baltimore
- Age
- 18 years and over
- People
- 6
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07140315 - Phase 1Taking peopleA Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Where
- Coral Springs, Duarte, East Brunswick, Fairfax, Fort Worth, Goodyear, Houston, Irving, Jacksonville, Nashville, New York, Omaha, Orlando, Philadelphia, Phoenix, Rochester, Santa Rosa, Seattle, Tampa, Washington D.C., West Valley City, Zion
- Age
- 18 years and over
- People
- 260
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07277413 - No phaseTaking peopleSPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier
- Where
- Salt Lake City
- Age
- 21 years and over
- People
- 240
- Run by
- University of Utah
See details and how to joinNCT07460440 - Phase 2Taking peoplePilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- Where
- Charlotte, Winston-Salem
- Age
- 18 years and over
- People
- 105
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT04253964 - Phase 3Taking peopleA Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- Where
- Aberdeen, Bay Pines, Bethesda, Bridgeton, Buffalo, Canton, Charleston, Chicago, Clearwater, Decatur, Des Moines, East Syracuse, Fountain Hill, Frederick, Fresh Meadows, Gainesville, Kittanning, La Mesa, Leawood, Lexington, Lincoln, Los Alamitos, Marietta, Morgantown, Newark, Owensboro, Paramus, Philadelphia, Reno, Renton, Rochester, Round Rock, Saginaw, Schofield, Silver Spring, St. Petersburg, Towson, Waterloo, Westbury
- Age
- 18 years and over
- People
- 830 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06868277 · EU 2024-517780-24-00 - No phaseTaking peopleDyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery
- Where
- Houston
- Age
- 18 years and over
- People
- 60
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06919874